Stifel Nicolaus Cuts 908 Devices (NASDAQ:MASS) Price Target to $6.00

908 Devices (NASDAQ:MASS) had its price objective decreased by Stifel Nicolaus from $17.00 to $6.00 in a research note published on Wednesday,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $4.00 target price (down from $12.00) on shares of 908 Devices in a research report on Wednesday.

908 Devices Stock Performance

Shares of MASS opened at $2.39 on Wednesday. 908 Devices has a 1 year low of $2.19 and a 1 year high of $12.51. The business has a 50-day moving average of $3.42 and a 200-day moving average of $4.65.

Institutional Trading of 908 Devices

Institutional investors have recently modified their holdings of the business. GAMMA Investing LLC bought a new position in shares of 908 Devices in the second quarter worth $48,000. SG Americas Securities LLC purchased a new stake in 908 Devices during the third quarter valued at about $36,000. State Board of Administration of Florida Retirement System bought a new position in 908 Devices during the 1st quarter worth approximately $80,000. Drive Wealth Management LLC purchased a new position in shares of 908 Devices in the third quarter worth $50,000. Finally, Townsquare Capital LLC purchased a new stake in shares of 908 Devices during the third quarter worth about $50,000. 88.06% of the stock is currently owned by hedge funds and other institutional investors.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.